Business Daily from THE HINDU group of publications
Wednesday, Sep 17, 2008
ePaper | Mobile/PDA Version | Audio
Business Daily from THE HINDU group of publications Wednesday, Sep 17, 2008 ePaper | Mobile/PDA Version | Audio |
|
|
|
|
|
Corporate
-
Outlook
Our Bureau Hyderabad, Sept. 16 Manufacturers of bulk drugs should invest in scaling-up their product diversity and quality, said Mr G.V. Prasad, Vice-Chairman and Chief Executive Officer of Dr Reddy’s Laboratories Ltd. Speaking on ‘Sustaining Competitive Environment in Industry’, a seminar organised by the Bulk Drug Manufacturers Association of India (BDMA) here on Tuesday, Mr Prasad said the bulk drug units should also increase their compliance with global regulatory norms to sustain growing competition from other countries. “One way to sustain competition is forging partnerships and alliances to increase value and expand offerings. We, at Dr Reddy’s, also believe in this,” he said. Dr Reddy’s has about 20 such industry partnerships/alliances which bring more than Rs 100 crore of value individually, he added. personalised medicineDr Lalji Singh, Director, Centre for Cellular and Molecular Biology, said the pharmaceutical industry needs to prepare itself for personalised medicine which would become prominent in the days to come. “With genome sequencing and increasing awareness about genomic medicine, people will become more aware/particular about the drug they use. You may have to suit drugs to the specific requirement of different genetic sections of population, especially for major disorders,” he said. Personalised medicine would be more relevant to India in view of the genetic diversity of its population, he added. More Stories on : Outlook | Pharmaceuticals | Dr. Reddy's Laboratories Ltd
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
